Javier Fernández-Ruiz is a PhD in Biochemistry obtained in 1986 in the Complutense University, Madrid, Spain. He is currently Full Professor in the Department of Biochemistry and Molecular Biology, Faculty of Medicine, in such university. Together with his teaching activities in the areas of Neurochemistry and Neurobiology, he has been working during the last 42 years in different diseases of the CNS, having authored 258 research articles and 45 review articles in international journals (H-index: 76). Also 42 chapters in national and international books and 8 international patents. He has supervised 24 doctoral thesis along 32 years. He has given lectures at different national and international universities and research centers, as well as numerous presentations at national and international congresses. He is currently the PI of the “Cannabinoids and Neurological Disorders” research group at the Complutense University, and also at two cooperative networks of excellence research in Spain: CIBERNED and IRYCIS. The group collaborates with several national and international groups, and different pharmaceutical companies. He has participated in numerous research projects, acting as PI in many of them, including 8 research contracts with pharma companies. He is currently a member of the Editorial Board in the British Journal of Pharmacology. He has been President of the International Cannabinoid Research Society (ICRS) (2002-2003) and member of its Executive Committee (2001-2004), as well as a founding member of the Spanish Cannabinoid Research Society (SEIC) and member of its Executive Committee (2000-2013) serving as President during 2007-2011. He received the IACM Special Award in 2019.

Dr. Fernández-Ruiz was ICRS President from 2002-3 and received the ICRS Mechoulam Award in 2021.